Therapeutic Vaccines for Genitourinary Malignancies

The field of genitourinary malignancies has been a showcase for therapeutic cancer vaccine success since the application of intravesicular Bacillus Calmette-Guerin (BCG) for bladder cancer in the 1970s and enjoyed a renaissance in 2010 with the US Food and Drug Administration (FDA) approval of sipul...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutcher, Giselle M. A., Bilen, Mehmet Asim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161030/
https://www.ncbi.nlm.nih.gov/pubmed/30103542
http://dx.doi.org/10.3390/vaccines6030055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161030/
https://www.ncbi.nlm.nih.gov/pubmed/30103542
http://dx.doi.org/10.3390/vaccines6030055

Ejemplares similares